As the UKHSA issues new essential health guidance for travellers going abroad, a leading testing expert warns of the increasing risks of European holidays.
PD-L1 Subgroup Benefits Most From Neoadjuvant Immunotherapy in Early Breast Cancer
Promising findings from two clinical trials at the San Antonio Breast Cancer Symposium (SABCS) suggest that adding immunotherapy to chemotherapy in the neoadjuvant setting may